Carol I. Matthews
Senior Director of Clinical Programming
United BioSource Corporation
Carol I. Matthews is Senior Director of Clinical Programming at United BioSource Corporation (UBC), where she mentors management-level programming staff. She develops, documents, and maintains a centralized macro library, and is responsible for the migration of SAS software. A SAS user since 1990, Carol is a frequent presenter at the Pharmaceutical Industry SAS Users Group (PharmaSUG).
The author also teaches the "SAS Programming Certificate for the Pharmaceutical Industry" course for Philadelphia University's continuing education program. The program addresses good programming practices, common clinical data sets, reporting with data _null, and SAS macros.
By This Author
Validating Clinical Trial Data Reporting with SAS®
By Carol I. Matthews and Brian C. Shilling
This indispensable guide focuses on validating programs written to support the clinical trial process from after the data collection stage to generating reports and submitting data and output to the Food and Drug Administration (FDA). The authors provide practical examples and tips for avoiding errors in your output.
Featured Authors
-
Ron Klimberg, PhD, is a professor at the Haub School of Business at Saint Joseph's University in Philadelphia, PA.
-
Robert N. Rodriguez retired from SAS in 2018 after serving as a senior director in research and development. Bob received a PhD in statistics from the University of North Carolina at Chapel Hill and was a research statistician at General Motors Research Laboratories before joining SAS.
-
Terisa Roberts is a director and Global Solution lead for Risk Modeling and Decisioning at SAS. She has extensive experience in quantitative risk management, regulatory compliance, and model governance and validation. She has worked in financial services, telecommunications, government, energy, and retail sectors.
-
Todd Case has been working in the pharmaceutical industry as a statistical programmer for over 20 years. He completed his MS in Epidemiology from Columbia University and has worked at Forest Laboratories (now Allergan), Genentech, Bristol-Myers Squibb, and Biogen. He currently works at Vertex Pharmaceuticals.